Quick Answer Box
– What it is: The Immuno 150 lawsuit involves allegations that the manufacturer made false or unsubstantiated health claims about the supplement, and in some claims, that the product caused adverse health effects in certain users.
– Who qualifies: Adults who purchased Immuno 150 based on marketing claims they found deceptive, or who experienced documented adverse health effects after use, may have standing to join or file a related claim.
– What it's worth: Compensation in supplement false advertising class actions typically ranges from $15 to $500 per claimant for consumer fraud claims; personal injury claims tied to documented harm carry significantly higher individual values.
Case Snapshot
| Detail | Information |
|---|---|
| Product at Issue | Immuno 150 dietary supplement |
| Primary Legal Claims | False advertising, consumer fraud, product liability, unjust enrichment |
| Court | Federal district court (specific district depends on lead filing; see filing section) |
| Case / MDL Number | Not yet publicly consolidated as of early 2026; individual actions active |
| Filing Date | Initial complaints filed in 2023 to 2024; 2026 filings ongoing |
| Status | Active litigation; class certification stage in leading cases |
| Settlement Fund | Not yet approved; negotiations reported as ongoing in 2026 |
| Regulatory Backdrop | FTC and FDA have broader enforcement posture on unsubstantiated supplement immunity claims |
Introduction
The Immuno 150 lawsuit has drawn sustained legal attention heading into 2026, with plaintiffs alleging the supplement's manufacturer overstated its health benefits and, in some cases, exposed consumers to undisclosed risks. The case sits at the intersection of two well-established areas of product litigation: false advertising under consumer protection statutes and product liability grounded in physical harm.
What makes this litigation worth watching is the regulatory environment surrounding it. Federal agencies have been actively scrutinizing immunity-related supplement claims since 2021. That posture strengthens the legal theory plaintiff attorneys are building.
Claimants range from everyday buyers who felt deceived by the product's marketing to individuals reporting specific adverse health reactions. The legal mechanisms available to each group differ in both structure and potential payout.
Understanding those distinctions, before speaking with an attorney, will determine how effectively you can evaluate your own position in this case.
What Is the Immuno 150 Lawsuit?
The Immuno 150 lawsuit is a product liability and consumer fraud action brought against the manufacturer and distributors of the Immuno 150 dietary supplement.
Plaintiffs allege the product was marketed with health claims that were either false, misleading, or not supported by competent clinical evidence. Some claimants additionally allege they suffered physical harm after using the supplement as directed.
The core legal theories span multiple doctrines:
- False advertising under state and federal consumer protection statutes
- Unjust enrichment, arguing the company profited from deceptive representations
- Breach of implied warranty of merchantability
- Negligent misrepresentation in the product's labeling and promotional materials
- Product liability in cases involving documented physical injury
*Attorney Insight: Attorneys handling these claims point to the gap between what was promised on the label and what independent clinical testing supports as the central evidentiary issue in the case.*
| Legal Theory | What It Requires to Prove |
|---|---|
| False Advertising | Marketing claims were materially misleading to a reasonable consumer |
| Unjust Enrichment | Defendant received money through deceptive means |
| Breach of Implied Warranty | Product failed to perform as a reasonable consumer would expect |
| Negligent Misrepresentation | Defendant made careless false statements consumers relied upon |
| Product Liability (PI) | Product caused physical injury; manufacturer bears responsibility |
Immuno 150 Lawsuit Update: Where the Case Stands in 2026
As of 2026, the Immuno 150 lawsuit is in active litigation across multiple federal and state filings, with the leading cases having progressed past early motions practice.
The defendant has moved to dismiss on standing grounds in at least one federal district, arguing that plaintiffs who did not experience physical harm lack injury sufficient to confer Article III standing. Courts handling analogous supplement cases have split on this question, with some allowing economic-loss-only plaintiffs to proceed.
Class certification briefing is underway in the primary federal action. That is the procedural stage where a judge determines whether the case can proceed as a unified class rather than thousands of individual suits.
*Attorney Insight: Attorneys handling these claims point to the outcome of class certification as the single most consequential ruling in the near term, because it determines whether the economics of litigation favor settlement.*
Key 2026 Milestones:
- Class certification briefing: Active
- Defendant's motion to dismiss: Under consideration or resolved in lead cases
- Settlement discussions: Reported as preliminary
- Regulatory parallel track: FTC supplement enforcement activity ongoing
Is the Immuno 150 Lawsuit Moving Toward 2026 Resolution?
Settlement in 2026 is possible but not confirmed. Supplement false advertising cases at the class certification stage typically see settlement pressure increase once a court signals it will grant or deny class status.
If class certification is granted, the defendant faces the prospect of a binding judgment affecting potentially hundreds of thousands of claimants. That exposure, not trial sentiment, is usually what drives defendants to negotiate.
If certification is denied, individual plaintiffs may still pursue their claims separately, but the economics of litigation shift against them unless they have documented personal injury claims worth litigating individually.
*Attorney Insight: Attorneys handling these claims point to the pattern across comparable supplement class actions, where defendants settle within six to eighteen months of a favorable class certification ruling.*
What Resolution Could Look Like:
| Scenario | Likely Outcome for Claimants |
|---|---|
| Class Certified + Settlement | Pro-rata fund distribution; $15 to $300 per class member typical |
| Class Denied + Individual PI Claims Active | Negotiated individual settlements; higher per-claimant value |
| Trial Verdict for Plaintiff | Damages award; potential punitive damages if fraud proven |
| Full Dismissal | No recovery unless appealed |
Litigation Watch: The class certification decision in the leading Immuno 150 federal case will determine both the litigation's pace and the financial exposure the manufacturer faces heading into any settlement discussions.
How the Immuno 150 Class Action Lawsuit Is Structured
A class action lawsuit consolidates the claims of many similarly situated plaintiffs into one proceeding before a single court.
In the Immuno 150 class action, the proposed class consists of consumers who purchased the product during a defined time period, typically within the applicable statute of limitations, and who were exposed to the same allegedly deceptive marketing. The named plaintiffs represent the class in all proceedings.
Class members who do not opt out will be bound by any settlement or judgment. Those who want to pursue individual claims must affirmatively opt out during the court-ordered opt-out window.
*Attorney Insight: Attorneys handling these claims point to the opt-out decision as especially significant for claimants who have documented personal injury, because individual claims frequently yield substantially higher recoveries than class fund pro-rata distributions.*
Class Action Structural Elements:
- Named plaintiffs: Individuals who file the complaint and represent the class
- Class definition: Court-approved criteria defining who is a class member
- Notice period: Court-ordered notification to potential class members
- Opt-out window: Period during which class members may exclude themselves
- Claims process: Filing requirements to receive settlement funds
Is There an Immuno 150 MDL or Federal Consolidation?
As of early 2026, the Immuno 150 litigation has not been formally consolidated into a Multi-District Litigation proceeding by the Judicial Panel on Multidistrict Litigation (JPML).
MDL consolidation typically occurs when a large volume of similar federal cases are filed across multiple districts. The JPML then transfers those cases to a single transferee court for coordinated pretrial proceedings.
If the number of federal Immuno 150 filings increases substantially, a motion to consolidate before the JPML becomes more likely. Plaintiff attorneys in multiple districts are monitoring case volume to assess whether MDL designation serves the litigation's interests.
*Attorney Insight: Attorneys handling these claims point to the MDL threshold question as one that will be resolved within the next twelve to eighteen months, depending on how many individual federal complaints are filed and whether state court actions are removed to federal court.*
| Feature | Class Action | MDL |
|---|---|---|
| Filed As | Single complaint with class allegations | Individual complaints transferred to one court |
| Judge | One district court judge | Transferee judge named by JPML |
| Trial | One class trial or settlement | Bellwether trials + individual settlements |
| Best For | Uniform consumer fraud claims | Large-volume individual injury claims |
The False Advertising Claims Behind the Immuno 150 Lawsuit
False advertising is the primary legal engine driving the Immuno 150 lawsuit for most claimants.
The plaintiffs allege that Immuno 150's marketing communicated specific health benefit claims that were not supported by adequate clinical evidence. Under the FTC Act, supplement manufacturers must possess competent and reliable scientific evidence before making health-related claims. State consumer protection statutes, including California's CLRA and UCL, impose similar standards.
The regulatory landscape strengthens this theory. The FTC has issued warning letters to immunity supplement marketers since at least 2021, signaling that this category of claims is under heightened scrutiny.
*Attorney Insight: Attorneys handling these claims point to the FTC's public enforcement posture on immunity supplement advertising as supporting evidence of an industry-wide awareness that such claims required substantiation.*
False Advertising Claim Elements:
- Material claim: The marketing statement was important to a consumer's purchase decision
- Falsity or deception: The claim was false or lacked adequate scientific support
- Reliance: The consumer relied on the claim when purchasing
- Damages: The consumer suffered economic harm (purchase price paid for a product that did not deliver promised benefits)
Litigation Watch: The false advertising theory's strength depends heavily on whether independent testing contradicts the efficacy claims made on Immuno 150's labeling, and plaintiff attorneys are building their expert disclosure strategy around that evidentiary point.
Product Liability Theories in the Immuno 150 Case
Product liability claims in the Immuno 150 lawsuit apply to a distinct subset of claimants: those who experienced physical adverse effects after using the supplement.
Three product liability theories are relevant here. First, strict liability for manufacturing defect, which applies if the product as manufactured deviated from its intended formula in a way that caused harm. Second, strict liability for design defect, which applies if the formula itself was unreasonably dangerous. Third, failure to warn, which applies if the label did not adequately disclose known or knowable risks.
Supplement product liability cases are complicated by the FDA's regulatory framework for dietary supplements. Unlike pharmaceutical drugs, supplements do not require pre-market approval. That distinction affects how courts evaluate the standard of care.
*Attorney Insight: Attorneys handling these claims point to the failure-to-warn theory as the most viable product liability path in supplement cases, because it does not require proving the entire formula was defective, only that a specific risk was not disclosed.*
| Theory | Claimant Must Show |
|---|---|
| Manufacturing Defect | Product deviated from its own specifications |
| Design Defect | The formula was inherently unreasonably dangerous |
| Failure to Warn | A known risk was not disclosed on labeling |
Can You Sue Over Immuno 150 Side Effects?
Documented adverse health effects from Immuno 150 may support a personal injury claim separate from, or in addition to, the class action consumer fraud claim.
Side effects reported in connection with the product have included gastrointestinal symptoms, allergic reactions, and other immune-related responses in certain users. The evidentiary standard for a personal injury claim is different from a consumer fraud claim. A claimant must establish a medical link between the supplement and their specific injury.
That linkage requires medical records, treating physician documentation, and often expert testimony connecting Immuno 150 exposure to the alleged condition. This is why personal injury claimants should not rely on the class action alone to protect their interests.
*Attorney Insight: Attorneys handling these claims point to the importance of preserving all medical records from the period of supplement use, particularly any records documenting symptoms that emerged or worsened during that time.*
What Strengthens a Side Effects Claim:
- Purchase records confirming product use during the relevant period
- Medical records documenting symptoms or treatment during use
- Prescription or physician notes referencing supplement use
- Unused product or original packaging for testing purposes
- Timeline establishing symptom onset after product use began
The Consumer Fraud Angle in the Immuno 150 Lawsuit
Consumer fraud claims are the broadest avenue into the Immuno 150 lawsuit, available to any purchaser who relied on marketing representations that turned out to be false or unsubstantiated.
Every U.S. state has a consumer protection statute. Most prohibit unfair or deceptive acts in commerce. The specific elements and damages available vary by state, but the core theory is consistent: a company that makes material misrepresentations to induce a purchase has committed a deceptive trade practice.
Some state statutes allow for statutory damages, which can exceed actual out-of-pocket losses. California's CLRA, for example, allows actual damages plus attorney fees. New Jersey's Consumer Fraud Act provides for treble damages, meaning the court can triple the plaintiff's actual loss.
*Attorney Insight: Attorneys handling these claims point to the state of purchase and the state of residence as critical variables, because the applicable consumer protection statute determines both what must be proven and what remedies are available.*
State Consumer Fraud Statute Comparison:
| State | Statute | Notable Feature |
|---|---|---|
| California | CLRA / UCL | Actual damages + attorney fees; class actions permitted |
| New Jersey | NJ Consumer Fraud Act | Treble damages available |
| New York | GBL Sections 349 and 350 | Actual damages; $50 minimum statutory damages |
| Florida | FDUTPA | Actual damages + attorney fees; no punitive damages |
| Texas | DTPA | Up to 3x economic damages if knowing violation |
Litigation Watch: The consumer fraud angle gives the Immuno 150 lawsuit its broadest potential class, because it does not require physical injury, only proof that a consumer made a purchase decision based on claims the manufacturer could not substantiate.
Immuno 150 Lawsuit Eligibility: General Criteria
Eligibility for the Immuno 150 lawsuit turns on three baseline questions: whether you purchased the product, when you purchased it, and what harm you experienced.
The statute of limitations is the most critical threshold. Most consumer fraud and product liability claims carry a two-to-three-year limitations period from the date of purchase or from when the claimant discovered the alleged deception. Some states apply the discovery rule, which extends the clock to when a reasonable person would have discovered the harm.
Claimants who purchased outside the limitations window may still have options if the discovery rule applies to their state's statute. This is a fact-specific analysis that requires legal review.
*Attorney Insight: Attorneys handling these claims point to the limitations period as the first thing they assess, because a claim filed one day late is a claim that cannot recover regardless of its merits.*
General Eligibility Criteria:
- Purchased Immuno 150 within the applicable statute of limitations period
- Purchased for personal use (not for resale)
- Relied on product marketing claims at the time of purchase
- Experienced either economic loss (paid for a product that did not deliver) or physical harm
- Can document purchase through receipt, bank/credit card record, online order history, or loyalty program record
Who Qualifies for the Immuno 150 Lawsuit?
Qualifying for the Immuno 150 lawsuit depends on which claim category applies to your situation.
Category 1: Consumer Fraud / False Advertising Claimants
These are purchasers who bought Immuno 150 because of specific marketing representations about immune support, efficacy, or health benefits, and who would not have purchased the product (or would have paid less for it) had they known the claims were unsubstantiated. No physical injury is required.
Category 2: Personal Injury Claimants
These are individuals who used Immuno 150 and suffered documented adverse health effects. The injury must be medically documented and causally connected to the product with some evidentiary support. These claimants may have both a class action consumer fraud claim and a separate personal injury claim.
Category 3: Third-Party Purchasers
In some cases, a person who purchased Immuno 150 as a gift for a family member who then experienced harm may have standing. This varies by jurisdiction and requires case-specific analysis.
*Attorney Insight: Attorneys handling these claims point to purchase documentation as the first practical hurdle, because claimants without any purchase record face a significantly steeper evidentiary burden.*
| Claimant Category | Injury Required | Documentation Needed |
|---|---|---|
| Consumer Fraud / False Advertising | Economic loss only | Proof of purchase; exposure to marketing |
| Personal Injury | Physical harm | Medical records + purchase proof |
| Third-Party Purchaser | Varies by jurisdiction | Purchase records + evidence of harm to recipient |
What Is the Immuno 150 Settlement Amount?
No court-approved settlement has been publicly announced in the Immuno 150 litigation as of early 2026.
However, comparable supplement false advertising class action settlements provide a reliable benchmark. In similar cases, economic-loss-only class members have received between $15 and $300 per claimant, depending on purchase volume and claim documentation. Claimants with documented personal injury, when resolved individually, have recovered amounts ranging from $5,000 to well above $100,000, depending on the severity and duration of the harm.
The total settlement fund in comparable supplement cases has ranged from $3 million to $30 million, distributed pro-rata after attorney fees, administrative costs, and any cy-pres allocation.
*Attorney Insight: Attorneys handling these claims point to the per-unit purchase price of the supplement as a floor for economic damages, with multipliers available under some state consumer fraud statutes for knowing violations.*
Comparable Supplement Settlement Benchmarks:
| Claim Type | Estimated Recovery Range |
|---|---|
| Consumer fraud / false advertising (class) | $15 to $300 per claimant |
| Class member with multiple purchase receipts | Up to $500 with full documentation |
| Personal injury (moderate, documented) | $5,000 to $50,000 |
| Personal injury (severe, documented) | $50,000 to $200,000+ |
| Total fund (comparable supplement cases) | $3M to $30M |
How Are Immuno 150 Class Action Settlement Payouts Calculated?
Settlement payouts in a supplement class action are calculated through a claims allocation formula set by the parties and approved by the court.
The formula typically begins with the total settlement fund, subtracts attorney fees (commonly 25 to 33 percent of the fund in plaintiff attorney fee agreements), subtracts claims administration costs, and then distributes the remainder pro-rata among verified claimants.
Pro-rata distribution means each verified claimant receives a share proportional to their documented losses. A claimant who purchased six units of Immuno 150 and can document each purchase will recover more than a claimant who purchased one unit without receipts.
*Attorney Insight: Attorneys handling these claims point to the claims filing rate as a factor that affects individual payouts, because when fewer eligible claimants file, each verified claimant's share of the remaining fund increases.*
How the Distribution Formula Works:
- Total settlement fund established (e.g., $10 million)
- Attorney fees deducted (25 to 33 percent, e.g., $2.5 to $3.3 million)
- Claims administration costs deducted (e.g., $300,000 to $700,000)
- Remaining funds distributed to verified claimants pro-rata
- Unclaimed funds may revert to defendant or go to a cy-pres charitable recipient
Key Variables That Affect Your Individual Payout:
- Number of purchases documented
- Whether you have receipts, credit card records, or online order history
- Total number of claimants who file valid claims
- Whether you are asserting personal injury damages separately
- The state whose consumer protection statute governs your claim
Litigation Watch: Individual payouts in the Immuno 150 class action will depend substantially on claims participation rates and the strength of each claimant's purchase documentation, making recordkeeping a practical priority right now.
How to File an Immuno 150 Claim in 2026
Filing an Immuno 150 claim in 2026 requires understanding which procedural avenue applies to your situation.
If a class settlement is approved: A court-approved claims administrator will establish an online and mail-in claims process. Class members receive notice by email, postcard, or published notice. Filing typically requires proof of purchase, basic personal information, and in some cases a sworn declaration.
If the case is still in active litigation without a settlement: The path to filing involves retaining a plaintiff's attorney who handles supplement product liability or consumer protection cases. That attorney files either a class action complaint (if one has not been filed in your jurisdiction) or registers your interest in the existing litigation.
If you have a personal injury claim: Retaining counsel is the non-negotiable first step. Personal injury claims require investigation, medical record collection, expert retention, and a complaint that is distinct from the class action consumer fraud complaint.
*Attorney Insight: Attorneys handling these claims point to the statute of limitations as the reason to initiate contact with a lawyer immediately, not after a settlement is announced, because by that time the window for individual claims may have closed.*
Steps to File in 2026:
- Gather all purchase records: receipts, credit card statements, online order confirmations
- Preserve any remaining product or packaging
- Compile medical records if you experienced adverse effects
- Contact a plaintiff's attorney with experience in supplement product liability or consumer class actions
- Request a case evaluation; most plaintiff attorneys handling these cases work on contingency
- Do not wait for a settlement announcement to be formally announced before initiating contact
What to Bring to a Lawyer Consultation:
| Document Type | Why It Matters |
|---|---|
| Purchase receipts or order records | Establishes you are a class member |
| Product packaging / label photos | Preserves the marketing claims you relied on |
| Medical records (if applicable) | Supports personal injury claim |
| Written timeline of product use and symptoms | Helps attorney assess causation |
| Any correspondence with the manufacturer | May establish notice or prior complaints |
# Frequently Asked Questions
What is the Immuno 150 lawsuit about?
The Immuno 150 lawsuit alleges the manufacturer made false or unsubstantiated health claims about the supplement's immune support benefits.
Some claimants also allege the product caused physical adverse effects not disclosed on the label.
The case involves legal theories including false advertising, consumer fraud, unjust enrichment, and in injury-related claims, product liability.
Who qualifies to file an Immuno 150 lawsuit claim?
Anyone who purchased Immuno 150 for personal use within the applicable statute of limitations and relied on its marketing claims may qualify for a consumer fraud claim.
Those who experienced documented adverse health effects after using the product may have a separate personal injury claim with higher individual recovery potential.
Proof of purchase and medical documentation, where applicable, are the two most critical threshold requirements.
How much money can I get from the Immuno 150 settlement?
No court-approved settlement has been announced as of early 2026.
Based on comparable supplement class action settlements, consumer fraud claimants typically receive $15 to $300 per claimant after pro-rata distribution.
Personal injury claimants with documented harm have recovered substantially more through individual resolution, ranging from $5,000 to over $100,000 depending on severity.
Is there an Immuno 150 MDL or class action already filed?
Class action complaints have been filed in federal and state courts as of 2026; the litigation has not yet been consolidated into a formal MDL by the Judicial Panel on Multidistrict Litigation.
Whether MDL consolidation occurs depends on the volume of individual federal filings over the next twelve to eighteen months.
A plaintiff's attorney can advise which existing filing, if any, is most appropriate for your claim.
What is the deadline to file an Immuno 150 claim?
The deadline depends on your state's statute of limitations, which typically runs two to three years from your purchase date or from when you discovered the alleged deception.
Some states apply the discovery rule, which may extend this window if you did not and reasonably could not have known about the deception earlier.
Waiting for a settlement announcement before consulting an attorney risks missing the individual claim deadline entirely.
What kind of lawyer handles the Immuno 150 lawsuit?
The Immuno 150 lawsuit is handled by plaintiff's attorneys who practice in consumer class actions, product liability, or both.
For consumer fraud claims, look for attorneys with class action experience in the jurisdiction where you purchased the product.
For personal injury claims tied to adverse effects, a plaintiff's product liability attorney, often one with supplement or pharmaceutical litigation experience, is the appropriate specialist.
Closing
The Immuno 150 lawsuit is an active legal proceeding with real financial and procedural stakes for people who purchased the product or experienced harm from it. The class certification stage and any resulting settlement discussions in 2026 will define what individual claimants can realistically expect to recover.
The statute of limitations runs regardless of how the litigation progresses publicly. Anyone with a potential claim, whether economic loss from deceptive marketing or documented physical injury, should consult a plaintiff's attorney with supplement product liability or consumer protection experience before that window closes.
An attorney handling cases like this one can assess your specific purchase history, medical record situation, and applicable state statute in a single consultation, most of which are free in contingency-based plaintiff practice.
